Education
1993 – Ph.D. (Economics), Wayne State University
1985 – MA (Economics), Central Michigan University
1982 – BS (Business & Economics), Central Michigan University
Research Interests
Economic Evaluation of Health Services
Current Research Projects
- Measuring Quality Adjusted Life Years in Children with Autism Spectrum Disorders, National Institute of Mental Health
- Evaluation of the Arkansas Marketplace Insurance Exchange, Arkansas Insurance Department (J. Mick Tilford, PI)
- Evaluation of the Arkansas Medicaid Expansion through the Private Option, (Joseph Thompson, PI)
- Enhanced Academic Detailing to Increase Immunization Recall Rates, Centers for Disease Control and Prevention (J. Gary Wheeler, PI)
- Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children, National Institutes of Health (Tamara Perry, PI)
Courses Taught
- HPMT 6320, HPMT 6321 Advanced Health Economics
- HPMT 5104/6104 Introduction to Health Economics
- HPMT 6213 Variation in Health System Performance
Recent Publications
Clare C. Brown, Jennifer E. Moore, Holly C. Felix, M. Kate Stewart, J. Mick Tilford. “County-level Variation in Low Birthweight and Preterm Birth: An Evaluation of State Medicaid Expansion under the Affordable Care Act.” Forthcoming in Medical Care.
Hsueh-Fen Chen, Reid Landes, Robert Schuldt, J. Mick Tilford. “Quality Performance of Rural and Urban Home Health Agencies: Implications for Rural Add-On Payment Policies.” Forthcoming in the Journal of Rural Health.
Clare C. Brown and J. Mick Tilford. Perinatal Outcomes in Medicaid Expansion and Non-expansion States Among Hispanic Women –Reply. JAMA. 2019 322(9):894. (Letter)
Clare C. Brown, Jennifer E. Moore, Holly C. Felix, Mary K. Stewart, T. Mac Bird, Curtis L. Lowery, J. Mick Tilford. “Association of State Medicaid Expansion Status with Low Birthweight and Preterm Birth.” JAMA. 2019 Apr 23;321(16):1598-1609
Scott D. Grosse, Jamison Pike, Rieza Soelaeman, J. Mick Tilford. “Quantifying Family Spillover Effects in Economic Evaluations: Measurement and Valuation of Informal Care Time.” Pharmacoeconomics. 2019Apr;37(4):461-473